IDO1 and neoplasm: Indoleamine 2,3-dioxigenase 1 (IDO1) is expressed by various cancer cells and immune cells in the tumor microenvironment, including T cells, dendritic cells (DCs), tumor-associated macrophages, mesenchymal stromal cells (MSCs), and myeloid-derived suppressor cells (MDSCs) (21, 22).